Everyday Health Receives $10.50/Share Cash Offer From j2

Everyday Health Inc EVDY
disclosed that it struck a definitive deal with Ziff Davis, LLC, which comprises
J2 Global IncJCOM
, enabling the latter to buy it for $10.50 a share in cash. This would translate in an enterprise value of approximately $465 million.

The agreement involves a condition that over 50 percent of shares of Everyday Health should be tenders to complete the transaction apart from regulatory approvals and other customary conditions.

Everyday indicated that its board got a fairness opinion from Qatalyst Partners and recommended shareholders to tender their shares to the offer.

The company's co-founder and CEO Ben Wolin commented, "We are pleased to have reached this agreement with Ziff Davis, which we believe is in the best interests of Everyday Health and our shareholders and represents the culmination of a thorough review of strategic alternatives for the Company."

Related Link: J2 Global Resumes Trading Up 6+% At $66.95

He added, "This compelling transaction delivers significant and immediate cash value to our shareholders, and positions Everyday Health to reach its next phase of growth. We look forward to working with the Ziff Davis team to ensure a seamless transition."

At Last Check ...

  • Everday was up 11.44 percent at $10.48.
  • J2 Global was up 4.28 percent at $65.37.

Full ratings data available on Benzinga Pro.

Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!
Posted In: NewsHealth CareM&AMoversTechTrading IdeasGeneralBen WolinQatalyst PartnersZiff Davis
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...